Marshall Wace’s KALA BIO KALA Stock Holding History

Marshall Wace’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6	Closed	-$129K	–	1766
2020 Q1	$129K	Buy	+6	New	+$95.9K	﹤0.01%	1275
2019 Q2	–	Sell	-16	Closed	-$325K	–	1596
2019 Q1	$325K	Buy	+16	New	+$284K	﹤0.01%	1242

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's KALA Position: Q2 2020 in Review

Marshall Wace sold out of KALA BIO (KALA) in Q2 2020, closing a stake of 6 shares — an estimated $129K sold.

Marshall Wace first reported a position in KALA in Q1 2019 and held it in 2 quarters. The position peaked at $325K in Q1 2019. 113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

Marshall Wace reported no remaining KALA BIO position as of Q2 2020 after selling out during the quarter.
Marshall Wace sold 6 KALA BIO shares in Q2 2020, an estimated $129K.
Marshall Wace first reported a position in KALA BIO in Q1 2019 and held it in 2 quarters.
Marshall Wace's KALA BIO position peaked at $325K in Q1 2019.
113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.